Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2011 2
2012 1
2014 1
2016 1
2017 1
2019 2
2020 2
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Cost-effectiveness of a medication event monitoring system for tuberculosis management in Morocco.
Yang J, Kim HY, Park S, Sentissi I, Green N, Oh BK, Kim Y, Oh KH, Paek E, Park YJ, Oh IH, Lee SH. Yang J, et al. PLoS One. 2022 Apr 19;17(4):e0267292. doi: 10.1371/journal.pone.0267292. eCollection 2022. PLoS One. 2022. PMID: 35439273 Free PMC article.
Two-way sensitive analysis was done for the treatment success rate between MEMS and standard of care. RESULTS: The average total per-patient health system costs for treating a new TB patient under MEMS versus standard of care were $398.70 and $155.70, respectively. …
Two-way sensitive analysis was done for the treatment success rate between MEMS and standard of care. RESULTS: The average total per- …
Prevalence of Mycobacterium tuberculosis Beijing genotype and its association with drug resistance in North India.
Mathuria JP, Srivastava GN, Sharma P, Mathuria BL, Ojha S, Katoch VM, Anupurba S. Mathuria JP, et al. J Infect Public Health. 2017 Jul-Aug;10(4):409-414. doi: 10.1016/j.jiph.2016.06.007. Epub 2016 Aug 2. J Infect Public Health. 2017. PMID: 27496592 Free article.
One hundred and twenty four M. tuberculosis isolates were analyzed with spoligotyping, further drug susceptibility testing was done by 1% proportional method. Out of these, 11 (8.9%) M. tuberculosis isolates were identified as Beijing and 113 (91.1%) as non-Beijing genotyp …
One hundred and twenty four M. tuberculosis isolates were analyzed with spoligotyping, further drug susceptibility testing was done b …
Evaluation of Antimicrobial Susceptibility Profile in Salmonella Typhi and Salmonella Paratyphi A: Presenting the Current Scenario in India and Strategy for Future Management.
Veeraraghavan B, Pragasam AK, Ray P, Kapil A, Nagaraj S, Perumal SPB, Saigal K, Thomas M, Gupta M, Rongsen-Chandola T, Jinka DR, Shastri J, Alexander AP, Koshy RM, De A, Singh A, Evelyn Ebenezer S, Dutta S, Bavdekar A, More D, Sanghavi S, Nayakanti RR, Jacob JJ, Amladi A, Anandan S, Abirami BS, Bakthavatchalam YD, Sethuvel DPM, John J, Kang G. Veeraraghavan B, et al. J Infect Dis. 2021 Nov 23;224(Supple 5):S502-S516. doi: 10.1093/infdis/jiab144. J Infect Dis. 2021. PMID: 35238369 Free PMC article.
Typhi (37%) compared with S. Paratyphi A (20%). Azithromycin susceptibility was 99.9% and 100% with a mean MIC of 4.98 mug/mL for S. ...Paratyphi A respectively. Ceftriaxone was the only agent that retained 100% susceptibility. Moreover, beta-lactam/beta-lact …
Typhi (37%) compared with S. Paratyphi A (20%). Azithromycin susceptibility was 99.9% and 100% with a mean MIC of 4.98 mug/mL …
The unprecedented epidemic-like scenario of dermatophytosis in India: III. Antifungal resistance and treatment options.
Verma SB, Panda S, Nenoff P, Singal A, Rudramurthy SM, Uhrlass S, Das A, Bisherwal K, Shaw D, Vasani R. Verma SB, et al. Indian J Dermatol Venereol Leprol. 2021 [SEASON];87(4):468-482. doi: 10.25259/IJDVL_303_20. Indian J Dermatol Venereol Leprol. 2021. PMID: 34219433 Free article. Review.
Though there appears to be discordance between in vivo and in vitro resistance, demonstration of in vitro resistance of dermatophytes to antifungals by antifungal susceptibility testing is essential as it may help in appropriate management. The practical problem in the int …
Though there appears to be discordance between in vivo and in vitro resistance, demonstration of in vitro resistance of dermatophytes to ant …
Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013-2017.
Okethwangu D, Birungi D, Biribawa C, Kwesiga B, Turyahabwe S, Ario AR, Zhu BP. Okethwangu D, et al. BMC Infect Dis. 2019 May 7;19(1):387. doi: 10.1186/s12879-019-4014-3. BMC Infect Dis. 2019. PMID: 31064332 Free PMC article.

The number of cases during January-August 2017 was 10, compared with 3-4 cases in January-August from 2013 to 2016 (p = 0.02). Men were more affected than women (6.5 vs 1.6/100,000, p < 0.01), as were cases 18 years old compared to those < 18 years (8.7 vs 0.21/100,0

…
The number of cases during January-August 2017 was 10, compared with 3-4 cases in January-August from 2013 to 2016 (p = 0.02). Men we …
The pattern of comorbidity and its prevalence among drug-resistant tuberculosis patients at treatment initiation in Lagos, Nigeria.
Adejumo OA, Olusola-Faleye B, Adepoju VA, Gidado M, Onoh MO, Adegboye O, Abdur-Razzaq H, Moronfolu O, Shogbamimu Y. Adejumo OA, et al. Trans R Soc Trop Med Hyg. 2020 Jun 1;114(6):415-423. doi: 10.1093/trstmh/trz126. Trans R Soc Trop Med Hyg. 2020. PMID: 31925446
BACKGROUND: Multimorbidity is increasingly being recognized as a serious public health concern in the control of both drug-susceptible and drug-resistant tuberculosis (DR-TB). This study assessed the pattern of comorbidities and their prevalence in DR-TB patients at treatm …
BACKGROUND: Multimorbidity is increasingly being recognized as a serious public health concern in the control of both drug-susceptible …
Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis in Tanzania: low accessibility of molecular diagnostic services and lack of healthcare worker empowerment in 28 districts of 5 high burden TB regions with mixed methods evaluation.
Mpagama SG, Mbelele PM, Chongolo AM, Lekule IA, Lyimo JJ, Kibiki GS, Heysell SK. Mpagama SG, et al. BMC Public Health. 2019 Apr 11;19(1):395. doi: 10.1186/s12889-019-6720-6. BMC Public Health. 2019. PMID: 30971228 Free PMC article.
Furthermore, the 2015 registers were audited for all drug-susceptible but retreatment TB cases and TB collaborative practices in HIV clinics, as these patients were in principal targeted for drug susceptibility testing by rapid molecular diagnostics. RESULTS: Twenty …
Furthermore, the 2015 registers were audited for all drug-susceptible but retreatment TB cases and TB collaborative practices in HIV …
Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test.
Cambau E, Chauffour-Nevejans A, Tejmar-Kolar L, Matsuoka M, Jarlier V. Cambau E, et al. PLoS Negl Trop Dis. 2012;6(7):e1739. doi: 10.1371/journal.pntd.0001739. Epub 2012 Jul 31. PLoS Negl Trop Dis. 2012. PMID: 22860144 Free PMC article.
BACKGROUND: Although leprosy is efficiently treated by multidrug therapy, resistance to first-line (dapsone, rifampin) and to second-line drugs (fluoroquinolones) was described worldwide. Since Mycobacterium leprae is not growing in vitro, phenotypic susceptibili …
BACKGROUND: Although leprosy is efficiently treated by multidrug therapy, resistance to first-line (dapsone, rifampin) and to …
Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
Sekar B, Arunagiri K, Kumar BN, Narayanan S, Menaka K, Oommen PK. Sekar B, et al. Lepr Rev. 2011 Mar;82(1):36-45. Lepr Rev. 2011. PMID: 21644470
Conventional Mouse foot-pad (MFP) assay for screening drug resistance in M. leprae is cumbersome and time-consuming (approximately 6 to 12 months). Molecular targets for different anti-leprosy drugs have been well defined. Molecular tools for rapid detection of drug resist …
Conventional Mouse foot-pad (MFP) assay for screening drug resistance in M. leprae is cumbersome and time-consuming (approximately 6 to 12 m …
Mycobacterium indicus pranii as stand-alone or adjunct immunotherapeutic in treatment of experimental animal tuberculosis.
Faujdar J, Gupta P, Natrajan M, Das R, Chauhan DS, Katoch VM, Gupta UD. Faujdar J, et al. Indian J Med Res. 2011 Nov;134(5):696-703. doi: 10.4103/0971-5916.90999. Indian J Med Res. 2011. PMID: 22199110 Free PMC article.
METHODS: BALB/c mice were infected with M. tuberculosis H37Rv (susceptible to all first and second line drugs) and three clinical isolates taken from the epository of the Institute. ...Chemotherapy (5 days/wk) was given one month after infection and the vaccinated group wa …
METHODS: BALB/c mice were infected with M. tuberculosis H37Rv (susceptible to all first and second line drugs) and three clinical iso …
13 results